Preserving Dose Intensity with Romiplostim Balances Bleeding Risk and GI Cancer Control in Patients With CIT – OncLive
- Preserving Dose Intensity with Romiplostim Balances Bleeding Risk and GI Cancer Control in Patients With CIT OncLive
- Oral Medication Proves Effective for Low Platelets Due to Chemotherapy University of Miami
- ASCO 2026 – Oral Drug Proved Highly Effective Against Chemotherapy-Related Low Platelets in GI Cancer Trial | Newswise Newswise
المصدر: Google News — Pakistan / HEALTH
0
مشاهدة





